Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Шоан" ООДfiledCritical"Шоан" ООД
Priority to BG101692ApriorityCriticalpatent/BG62512B1/en
Publication of BG101692ApublicationCriticalpatent/BG101692A/en
Publication of BG62512B1publicationCriticalpatent/BG62512B1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The means can be used in particular in endemic goitre andother diseases caused by iodine deficiency in the organism. Themeans contains concentrate of mineral water having ionic contentfrom 10 to 1000 mg/l, phenylalanine-L-form, vitamin E andantimicrobial substance. It reduces the risk of overdosage ofiodine in the organism, and no unfavourable side effects areproduced. Iodine is introduced in the blood stream covering theiodine deficiency.2 claims
BG101692A1997-06-271997-06-27Means for prevention and treatment of iodine-deficient conditions
BG62512B1
(en)